Please login to the form below

Not currently logged in
Email:
Password:

product recall

This page shows the latest product recall news and features for those working in and with pharma, biotech and healthcare.

J&J to FDA: there really is no asbestos in Baby Powder

J&J to FDA: there really is no asbestos in Baby Powder

product, which sparked a recall. ... Tests were also done on three lots manufactured before and after the recall, but were also negative, says J&J.

Latest news

More from news
Approximately 3 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    DePuy then announced a voluntary recall of its ASR metal-on-metal hip replacement system after a study showed that the five-year failure rate for the product was about 13%. ... This will help  to detect counterfeit devices and  to ensure that, where

  • Harnessing the power of ethnography in healthcare Harnessing the power of ethnography in healthcare

    Digital billboards can incorporate eye-tracking software which, when combined with interviews, can measure visual effect and product recall. ... We work in an industry where evidence should underpin everything we do, from product development to marketing

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...